Saturday, June 28, 2025

Latest:

A culturally sensitive approach for pediatricians to navigate co-sleeping conversations with families
Baylor recognizes faculty excellence in research with DeBakey Awards
What you need to know about sickle cell disease
From a terrifying diagnosis to training for a marathon: Abigail’s miracle story
Researchers uncover rare gene variants contributing to systemic sclerosis risk

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

Langerhans cell histiocytosis

From The Labs

Paving the way to better diagnosis and treatment for Langerhans cell histiocytosis

April 10, 2025 BRAFV600E mutation, Langerhans cell histiocytosis, Myeloid Neoplasia, Research, risk stratification

The findings create possibilities for risk-stratification regimens that can be better tailored to individual patients.

From The Labs

A promising two-punch therapy for Langerhans cell histiocytosis

June 29, 2021 dendritic cells, Langerhans cell histiocytosis, MAPK inhibitor, PD-1 receptors, rare cancer, Research, T-cell exhaustion

A novel combination therapy resulted in a significant decrease of disease burden in an animal model of LCH.

From The Labs

The 2019 Michael E. DeBakey M.D. Awards for Excellence in Research

May 16, 2019 2019 DeBakey research awards, Batten disease, C. difficile, heart attack, Langerhans cell histiocytosis, lysosomal storage disorders, Neurodegeneration, NIH Roadmap Epigenomics, Research, trehalose, tropinin

The 2019 Michael E. DeBakey M.D. Award for Research Excellence ceremony honored five Baylor College of Medicine faculty members for their excellence in published scientific

From the Labs: a closer look at metastatic medulloblastoma